DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Breithardt G, Baumgartner H, Berkowitz SD. , et al; ROCKET AF Steering Committee & Investigators.
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.
Eur Heart J 2014;
35 (47) 3377-3385
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.